2021 Annual Meeting | IS2 - Invited Science: Movement Disorders
Program Materials Program Evaluations
| 04:00 PM - 04:05 PM EDT | Introduction |
Introduction
Irene Malaty, MD, FAAN, Andrew D. Siderowf, MD |
| 04:05 PM - 04:15 PM EDT | Speaker |
Discrimination of alpha-synuclein strains and sub-strains in Synucleinopathies
Mohammad Shahnawaz, PhD |
| 04:15 PM - 04:25 PM EDT | Speaker |
Determinants of Health-Related Quality of Life in a Large, Online Cohort of Individuals with Parkinson’s Disease
Meredith Bock, MD |
| 04:25 PM - 04:35 PM EDT | Speaker |
The severity and distribution of tau pathology distinguish corticobasal degeneration and progressive supranuclear palsy: Machine learning-based approach
Shunsuke Koga, MD, PhD |
| 04:35 PM - 04:45 PM EDT | Speaker |
KMT2B-related disorders: Expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation
Diane Demailly |
| 04:45 PM - 05:00 PM EDT | Q&A |
Live Q&A and Closing Remarks
Irene Malaty, MD, FAAN, Meredith Bock, MD, Andrew D. Siderowf, MD, Mohammad Shahnawaz, PhD, Diane Demailly, Shunsuke Koga, MD, PhD |
| Irene Malaty, MD, FAAN | Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities. |
| Andrew D. Siderowf, MD | Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer-Ingelheim. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for askbio. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for capsida. Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parkinson Study Group. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prilenia. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogastrix. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alerity. Dr. Siderowf has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clintrex. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Siderowf has a non-compensated relationship as a Scientific Advisory Board with NeuroPacs that is relevant to AAN interests or activities. |
| Mohammad Shahnawaz, PhD | The institution of Dr. Shahnawaz has received research support from American Parkinson Disease Association. The institution of Dr. Shahnawaz has received research support from NIH. The institution of Dr. Shahnawaz has received research support from Texas Alzheimer's Research & Care Consortium . Dr. Shahnawaz has received intellectual property interests from a discovery or technology relating to health care. |
| Meredith Bock, MD | The institution of Dr. Bock has received research support from 好色先生. The institution of Dr. Bock has received research support from Michael J Fox Foundation. |
| Diane Demailly | Diane Demailly has nothing to disclose. |
| Shunsuke Koga, MD, PhD | Dr. Koga has nothing to disclose. |